- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x GLC- GLA: alpha-D-galactopyranose-(1-6)-alpha-D-glucopyranose(Non-covalent)
- 8 x TLA: L(+)-TARTARIC ACID(Non-covalent)
TLA.2: 5 residues within 4Å:- Chain A: H.139, L.335, S.336, R.552
- Ligands: EDO.11
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:S.336, A:R.552
- Water bridges: A:E.337
- Salt bridges: A:H.139, A:R.552
TLA.3: 5 residues within 4Å:- Chain A: T.254, E.255, L.653, I.654, N.655
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:E.255, A:L.653, A:N.655, A:N.655
- Water bridges: A:E.255, A:D.256, A:L.653, A:K.694
TLA.14: 5 residues within 4Å:- Chain B: H.139, L.335, S.336, R.552
- Ligands: EDO.23
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:S.336, B:R.552
- Water bridges: B:E.337
- Salt bridges: B:H.139, B:R.552
TLA.15: 5 residues within 4Å:- Chain B: T.254, E.255, L.653, I.654, N.655
8 PLIP interactions:8 interactions with chain B- Hydrogen bonds: B:E.255, B:L.653, B:N.655, B:N.655
- Water bridges: B:E.255, B:D.256, B:L.653, B:K.694
TLA.26: 5 residues within 4Å:- Chain C: H.139, L.335, S.336, R.552
- Ligands: EDO.35
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:S.336, C:R.552
- Water bridges: C:E.337
- Salt bridges: C:H.139, C:R.552
TLA.27: 5 residues within 4Å:- Chain C: T.254, E.255, L.653, I.654, N.655
7 PLIP interactions:7 interactions with chain C- Hydrogen bonds: C:E.255, C:L.653, C:N.655, C:N.655
- Water bridges: C:D.256, C:L.653, C:K.694
TLA.38: 5 residues within 4Å:- Chain D: H.139, L.335, S.336, R.552
- Ligands: EDO.47
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:S.336, D:R.552
- Water bridges: D:E.337
- Salt bridges: D:H.139, D:R.552
TLA.39: 5 residues within 4Å:- Chain D: T.254, E.255, L.653, I.654, N.655
7 PLIP interactions:7 interactions with chain D- Hydrogen bonds: D:E.255, D:L.653, D:N.655, D:N.655
- Water bridges: D:D.256, D:L.653, D:K.694
- 36 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.4: 6 residues within 4Å:- Chain A: L.50, H.52, L.53, D.198, F.199, P.200
Ligand excluded by PLIPEDO.5: 10 residues within 4Å:- Chain A: N.130, G.131, S.137, P.138, M.141, T.165, A.174, S.175, Y.176, V.308
Ligand excluded by PLIPEDO.6: 5 residues within 4Å:- Chain A: N.386, R.387, F.388, N.400, K.403
Ligand excluded by PLIPEDO.7: 7 residues within 4Å:- Chain A: E.662, Y.677, R.679, E.688, T.689, V.723, L.725
Ligand excluded by PLIPEDO.8: 5 residues within 4Å:- Chain A: A.202, D.203, K.277, N.281
- Ligands: EDO.9
Ligand excluded by PLIPEDO.9: 9 residues within 4Å:- Chain A: A.202, D.203, Y.204, Q.223, V.224, K.277, N.281, V.283
- Ligands: EDO.8
Ligand excluded by PLIPEDO.10: 3 residues within 4Å:- Chain A: R.24, I.25, I.125
Ligand excluded by PLIPEDO.11: 2 residues within 4Å:- Chain A: S.140
- Ligands: TLA.2
Ligand excluded by PLIPEDO.12: 4 residues within 4Å:- Chain A: P.200, Y.204, F.261
- Chain C: K.692
Ligand excluded by PLIPEDO.16: 6 residues within 4Å:- Chain B: L.50, H.52, L.53, D.198, F.199, P.200
Ligand excluded by PLIPEDO.17: 10 residues within 4Å:- Chain B: N.130, G.131, S.137, P.138, M.141, T.165, A.174, S.175, Y.176, V.308
Ligand excluded by PLIPEDO.18: 5 residues within 4Å:- Chain B: N.386, R.387, F.388, N.400, K.403
Ligand excluded by PLIPEDO.19: 7 residues within 4Å:- Chain B: E.662, Y.677, R.679, E.688, T.689, V.723, L.725
Ligand excluded by PLIPEDO.20: 5 residues within 4Å:- Chain B: A.202, D.203, K.277, N.281
- Ligands: EDO.21
Ligand excluded by PLIPEDO.21: 9 residues within 4Å:- Chain B: A.202, D.203, Y.204, Q.223, V.224, K.277, N.281, V.283
- Ligands: EDO.20
Ligand excluded by PLIPEDO.22: 3 residues within 4Å:- Chain B: R.24, I.25, I.125
Ligand excluded by PLIPEDO.23: 2 residues within 4Å:- Chain B: S.140
- Ligands: TLA.14
Ligand excluded by PLIPEDO.24: 4 residues within 4Å:- Chain B: P.200, Y.204, F.261
- Chain D: K.692
Ligand excluded by PLIPEDO.28: 6 residues within 4Å:- Chain C: L.50, H.52, L.53, D.198, F.199, P.200
Ligand excluded by PLIPEDO.29: 10 residues within 4Å:- Chain C: N.130, G.131, S.137, P.138, M.141, T.165, A.174, S.175, Y.176, V.308
Ligand excluded by PLIPEDO.30: 5 residues within 4Å:- Chain C: N.386, R.387, F.388, N.400, K.403
Ligand excluded by PLIPEDO.31: 7 residues within 4Å:- Chain C: E.662, Y.677, R.679, E.688, T.689, V.723, L.725
Ligand excluded by PLIPEDO.32: 5 residues within 4Å:- Chain C: A.202, D.203, K.277, N.281
- Ligands: EDO.33
Ligand excluded by PLIPEDO.33: 9 residues within 4Å:- Chain C: A.202, D.203, Y.204, Q.223, V.224, K.277, N.281, V.283
- Ligands: EDO.32
Ligand excluded by PLIPEDO.34: 3 residues within 4Å:- Chain C: R.24, I.25, I.125
Ligand excluded by PLIPEDO.35: 2 residues within 4Å:- Chain C: S.140
- Ligands: TLA.26
Ligand excluded by PLIPEDO.36: 4 residues within 4Å:- Chain A: K.692
- Chain C: P.200, Y.204, F.261
Ligand excluded by PLIPEDO.40: 6 residues within 4Å:- Chain D: L.50, H.52, L.53, D.198, F.199, P.200
Ligand excluded by PLIPEDO.41: 10 residues within 4Å:- Chain D: N.130, G.131, S.137, P.138, M.141, T.165, A.174, S.175, Y.176, V.308
Ligand excluded by PLIPEDO.42: 5 residues within 4Å:- Chain D: N.386, R.387, F.388, N.400, K.403
Ligand excluded by PLIPEDO.43: 7 residues within 4Å:- Chain D: E.662, Y.677, R.679, E.688, T.689, V.723, L.725
Ligand excluded by PLIPEDO.44: 5 residues within 4Å:- Chain D: A.202, D.203, K.277, N.281
- Ligands: EDO.45
Ligand excluded by PLIPEDO.45: 9 residues within 4Å:- Chain D: A.202, D.203, Y.204, Q.223, V.224, K.277, N.281, V.283
- Ligands: EDO.44
Ligand excluded by PLIPEDO.46: 3 residues within 4Å:- Chain D: R.24, I.25, I.125
Ligand excluded by PLIPEDO.47: 2 residues within 4Å:- Chain D: S.140
- Ligands: TLA.38
Ligand excluded by PLIPEDO.48: 4 residues within 4Å:- Chain B: K.692
- Chain D: P.200, Y.204, F.261
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hobbs, J.K. et al., Molecular analysis of an enigmaticStreptococcus pneumoniaevirulence factor: The raffinose-family oligosaccharide utilization system. J.Biol.Chem. (2019)
- Release Date
- 2019-10-02
- Peptides
- Alpha-galactosidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x GLC- GLA: alpha-D-galactopyranose-(1-6)-alpha-D-glucopyranose(Non-covalent)
- 8 x TLA: L(+)-TARTARIC ACID(Non-covalent)
- 36 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Hobbs, J.K. et al., Molecular analysis of an enigmaticStreptococcus pneumoniaevirulence factor: The raffinose-family oligosaccharide utilization system. J.Biol.Chem. (2019)
- Release Date
- 2019-10-02
- Peptides
- Alpha-galactosidase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A